The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis–Related Diabetes
Open accessAbstract
Cystic fibrosis-related diabetes (CFRD) is the most common comorbidity in subjects with cystic fibrosis (CF).A consensus conference on CFRD was cosponsored by the Cystic Fibrosis Foundation (CFF), the American Diabetes Association (ADA), and the Pediatric Endocrine Society (PES) in September 2009.The committee's evidencebased recommendations for clinical management of CFRD are published in this issue of Diabetes Care.This review article describes the epidemiology, pathogenesis, and prognostic implications of CFRD. EpidemiologyCFRD is part of a continuum of glucose tolerance abnormalities, ranging from normal glucose tolerance (NGT), to impaired glucose tolerance (IGT), to CFRD without fasting hyperglycemia (CFRD FHϪ), to CFRD with fasting hyperglycemia (CFRD FHϩ) (Fig. 1).Unlike patients with type 1 diabetes, those with CFRD do not develop complete absence of insulin secretion.At the other end of the spectrum, few CF patients have truly normal glucose metabolism.Approximately 20% of children who are categorized as having NGT based on their fasting and 2-h oral glucose tolerance test (OGTT) glucose levels have glucose elevation Ͼ200 mg/dl (11.1 mmol/l) mid-OGTT, which is termed indeterminate glycemia (INDET) (1).As in the general population where INDET is a risk factor for progression to diabetes (2), INDET in children with CF is associated with early development of CFRD (1).Home continuous glucose monitoring (CGM) has shown that intermittent, asymptomatic hyperglycemia is common even in CF patients whose OGTT is normal, but the prognostic significance of these early impairments in glucose metabolism is unknown (3,4).Impaired fasting glucose has also been described in CF (5,6).CFRD is present in about 20% of adolescents and 40 -50% of adults with CF (7) (Fig. 2).It is rare in childhood but has been described in children of all ages including infants (8 -11).Beginning in the teenage years, the incidence is ϳ3%, with some but not all centers reporting an overall female predominance (7,12).In younger individuals CFRD FHϪ predominates, but the prevalence of fasting hyperglycemia rises with age (7).Diabetes is associated with more severe CF gene mutations, increasing age, worse pulmonary function, undernutrition, liver dysfunction, pancreatic insufficiency, and corticosteroid use (12-15).Pathophysiology CFRD shares features of both type 1 and type 2 diabetes, but has enough pathophysiological and clinical differences to warrant separate diagnostic classification (Table 1).As in type 1 diabetes, individuals with CFRD are not obese, it often occurs in young people, insulin insufficiency is the primary defect, and metabolic syndrome features (hyperlipidemia, hypertension, visceral adiposity) are not usually present.Clinical management is similar to type 1 diabetes in the honeymoon phase.As in type 2 diabetes, this is not an autoimmune disease, insulin resistance is present (albeit usually mild), and ketosis is rare.Genetically, CFRD may be related to type 2 diabetes, as described below.Insulin insufficiency.Reduced -cell mass leading to insulin insufficiency is the hallmark of CFRD.The CF gene defect leads to abnormal or absent CF transmembrane conductance regulator (CFTR), a chloride channel that also influences sodium and water transport.Thick, viscous secretions cause inflammation, obstruction, and destruction of small ducts in the lungs, pancreas, liver, and reproductive organs.Autopsy findings include fibrosis and atrophy of the pancreas with ϳ50% reduction of the total islet mass (16 -18).Multiple studies have shown impaired first-phase insulin secretion in response to glucose, arginine, or glucagon, even in subjects with .In response to oral glucose, the earliest defect is delayed insulin secretion, followed over time by a progressively diminished total insulin response (22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32).The -cell destruction is not complete and residual endogenous insulin secretion is present, so these patients are not prone to ketosis.The lack of ketosis may also be related to low glucagon levels.While fasting glucagon levels are normal, CF patients are not able to appropriately increase glucagon secretion in response to arginine or hypoglycemia (21,24), consistent with reduced ␣-cell mass.Incretin levels (gastric
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality
Moran, A., Dunitz, J., Nathan, B., Saeed, A., Holme, B., & Thomas, W. (2009) · Diabetes Care · doi:10.2337/dc09-0586 · Cited by 648
Self-citationMILLA, C. E., WARWICK, W. J., & MORAN, A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9904075 · Cited by 367
Self-citationEpidemiology of cystic fibrosis-related diabetes
Marshall, B. C., Butler, S. M., Stoddard, M., Moran, A. M., Liou, T. G., & Morgan, W. J. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.12.039 · Cited by 327
Self-citationDiabetes mellitus associated with cystic fibrosis
Finkelstein, S. M., Wielinski, C. L., Elliott, G. R., Warwick, W. J., Barbosa, J., Wu, S.-C., & Klein, D. J. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80315-9 · Cited by 290
Lanng, S., Thorsteinsson, B., Nerup, J., & Koch, C. (1992) · European Journal of Pediatrics · doi:10.1007/bf01957574 · Cited by 267
Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia
Moran, A., Pekow, P., Grover, P., Zorn, M., Slovis, B., Pilewski, J., Tullis, E., Liou, T. G., Allen, H., & the Cystic Fibrosis Related Diabetes Therapy Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0585 · Cited by 240
Self-citationKoch, C., Rainisio, M., Madessani, U., Harms, H. K., Hodson, M. E., Mastella, G., McKenzie, S. G., Navarro, J., & Strandvik, B. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1142 · Cited by 218
Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections
Lanng, S., Thorsteinsson, B., Nerup, J., & Koch, C. (1994) · Acta Paediatrica · doi:10.1111/j.1651-2227.1994.tb13156.x · Cited by 210
Milla, C. E., Billings, J., & Moran, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2141 · Cited by 210
Self-citationMicrovascular Complications in Cystic Fibrosis–Related Diabetes
Schwarzenberg, S. J., Thomas, W., Olsen, T. W., Grover, T., Walk, D., Milla, C., & Moran, A. (2007) · Diabetes Care · doi:10.2337/dc06-1576 · Cited by 199
Self-citationAirway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis
Brennan, A. L., Gyi, K. M., Wood, D. M., Johnson, J., Holliman, R., Baines, D. L., Philips, B. J., Geddes, D. M., Hodson, M. E., & Baker, E. H. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.03.009 · Cited by 198
Pancreatic endocrine function in cystic fibrosis
Moran, A., Diem, P., Klein, D. J., Levitt, M. D., & Robertson, R. P. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80032-0 · Cited by 189
Self-citationEndocrine pancreas in cystic fibrosis: An immunohistochemical study
Iannucci, A., Mukai, K., Johnson, D., & Burke, B. (1984) · Human Pathology · doi:10.1016/s0046-8177(84)80191-4 · Cited by 162
Glucose Tolerance and Insulin Secretion, Morbidity, and Death in Patients with Cystic Fibrosis
Bismuth, É., Laborde, K., Taupin, P., Velho, G., Ribault, V., Jennane, F., Grasset, E., Sermet‐Gaudelus, I., Jacques de, B. L. I. C., Lenoir, G., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.09.025 · Cited by 147
Insulin Sensitivity in Cystic Fibrosis
Moran, A., Pyzdrowski, K. L., Weinreb, J. E., Kahn, B. B., Smith, S. A., Adams, K. S., & Seaquist, E. R. (1994) · Diabetes · doi:10.2337/diab.43.8.1020 · Cited by 144
Self-citationRolón, M. D. V., Benali, K., Munck, À., Navarro, J., Clément, A., Tubiana‐Rufi, N., Czernichow, P., & Polak, M. (2001) · Acta Paediatrica · doi:10.1111/j.1651-2227.2001.tb02446.x · Cited by 143
Diabetes mellitus in cystic fibrosis is characterized by islet amyloidosis
Couce, M., O’Brien, T. D., Moran, A., Roche, P. C., & Butler, P. C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772610 · Cited by 129
Self-citationOral glucose tolerance testing in children with cystic fibrosis
Ode, K. L., Frohnert, B. I., Laguna, T. A., Phillips, J., Holme, B., Regelmann, W. E., Thomas, W. T. B., & Moran, A. (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00632.x · Cited by 125
Self-citationBlackman, S. M., Hsu, S., Ritter, S. E., Naughton, K., Wright, F. A., Drumm, M. L., Knowles, M. R., & Cutting, G. R. (2009) · Diabetologia · doi:10.1007/s00125-009-1436-2 · Cited by 124
Mechanisms of insulin resistance in cystic fibrosis
Hardin, D. S., Leblanc, A., Marshall, G. D., & Seilheimer, D. K. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.5.e1022 · Cited by 121
Cystic fibrosis associated islet changes may provide a basis for diabetes
L�hr, M., Goertchen, P., Nizze, H., Gould, N., Gould, V. E., Oberholzer, M., Heitz, P. U., & Klöppel, G. (1989) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00718598 · Cited by 118
Conventional measures underestimate glycaemia in cystic fibrosis patients
Dobson, L., Sheldon, C. D., & Hattersley, A. T. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01219.x · Cited by 113
Abnormal lipid concentrations in cystic fibrosis
Figueroa, V., Milla, C. E., Parks, E. J., Schwarzenberg, S. J., & Moran, A. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.6.1005 · Cited by 110
Self-citationInsulin resistance is associated with decreased clinical status in cystic fibrosis
Hardin, D. S., LeBlanc, A., Lukenbaugh, S., & Seilheimer, D. K. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70282-8 · Cited by 107
Lanng, S., Thorsteinsson, B., Røder, M. E., Ørskov, C., Holst, J. J., Nerup, J., & Koch, C. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280207 · Cited by 107
Mozzillo, E., Franzese, A., Valerio, G., Sepe, A. O., Simone, I. D., Mazzarella, G., Ferri, P., & Raia, V. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00451.x · Cited by 107
Genetic Determinants and Epidemiology of Cystic Fibrosis–Related Diabetes
Adler, A., Shine, B. S. F., Chamnan, P., HAWORTH, C. S., & Bilton, D. (2008) · Diabetes Care · doi:10.2337/dc08-0466 · Cited by 100
Microvascular complications in patients with cystic fibrosis-related diabetes (CFRD)
van den Berg, J. M. W., Morton, A. M., Kok, S. W., Pijl, H., Conway, S. P., & Heijerman, H. G. M. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.05.008 · Cited by 97
Long-Term Effect of Insulin Treatment in Cystic Fibrosis-Related Diabetes
Mohan, K., Israel, K. L., Miller, H., Grainger, R., Ledson, M. J., & Walshaw, M. J. (2007) · Respiration · doi:10.1159/000110206 · Cited by 97
Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus
Nousia‐Arvanitakis, S., Galli‐Τsinopoulou, A., & Karamouzis, M. (2001) · Acta Paediatrica · doi:10.1111/j.1651-2227.2001.tb00791.x · Cited by 97
Bizzarri, C., Lucidi, V., Ciampalini, P., Bella, S., Russo, B., & Cappa, M. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03345538 · Cited by 89
Lanng, S., Thorsteinsson, B., Rsder, M. E., Nerup, J., & Koch, C. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02533.x · Cited by 87
Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
Hardin, D. S., LeBlanc, A., Para, L. H., & Seilheimer, D. K. (1999) · Diabetes · doi:10.2337/diabetes.48.5.1082 · Cited by 86
Cystic Fibrosis–Related Diabetes
Andersen, H. U., Lanng, S., Pressler, T., Laugesen, C. S., & Mathiesen, E. R. (2006) · Diabetes Care · doi:10.2337/dc06-0654 · Cited by 86
Increased glucose excursion in cystic fibrosis and its association with a worse clinical status
Costa, M., Potvin, S., Hammana, I., Malet, A., Berthiaume, Y., Jeanneret, A., Lavoie, A., Levesque, R. L., Perrier, J., Poisson, D., et al. (2007) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2007.02.005 · Cited by 83
Lombardo, F., Luca, F. D., Rosano, M., et al. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490053 · Cited by 83
Genetic Modifiers Play a Substantial Role in Diabetes Complicating Cystic Fibrosis
Blackman, S. M., Hsu, S., Vanscoy, L. L., Collaco, J. M., Ritter, S. E., Naughton, K., & Cutting, G. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2186 · Cited by 79
Moran, A., Milla, C. E., duCret, R. P., & Nair, K. S. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1336 · Cited by 78
Self-citationSosenko, J. M., Palmer, J. P., Rafkin-Mervis, L., Krischer, J. P., Cuthbertson, D., Mahon, J., Greenbaum, C. J., Cowie, C. C., Skyler, J. S., & the Diabetes Prevention Trial–Type 1 Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2140 · Cited by 76
Sims, E. J., Green, M. W., & Mehta, A. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1581 · Cited by 72
Glucose intolerance in children with cystic fibrosis
Solomon, M. P., Wilson, D. C., Corey, M. L., Kalnins, D., Zielenski, J., Tsui, L., Pencharz, P. B., Durie, P. R., & Sweezey, N. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.5 · Cited by 69
Pancreatic alpha and beta cell functions in cystic fibrosis
Lippe, B. M., Sperling, M. A., & Dooley, R. R. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)81241-9 · Cited by 69
Diabetes mellitus in cystic fibrosis: genetic and immunological markers
Lanng, S., Thorsteinsson, B., Pociot, F., Marshall, M. O., Madsen, H. O., Schwartz, M., Nerup, J., & Koch, C. (1993) · Acta Paediatrica · doi:10.1111/j.1651-2227.1993.tb12628.x · Cited by 68
Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis
Ahmad, T., NELSON, R. L., & Taylor, R. (1994) · Metabolism · doi:10.1016/0026-0495(94)90239-9 · Cited by 67
Proteolysis Associated With Insulin Resistance in Cystic Fibrosis
Hardin, D. S., Leblanc, A., Lukenbaugh, S., Para, L., & Seilheimer, D. K. (1998) · PEDIATRICS · doi:10.1542/peds.101.3.433 · Cited by 66
Continuous Glucose Monitoring in Cystic Fibrosis Patients According to the Glucose Tolerance
Moreau, F., Weiller, M., Rosner, V., Weiss, L. M., Hasselmann, M., Pinget, M., Kessler, R., & Kessler, L. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1062723 · Cited by 65
DIABETES MELLITUS IN CYSTIC FIBROSIS
Hardin, D. S., & Moran, A. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70102-x · Cited by 63
Self-citationRafii, M., Chapman, K., Stewart, C., et al. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn.81.2.421 · Cited by 56
Elder, D. A., Wooldridge, J. L., Dolan, L. M., & D’Alessio, D. A. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.05.012 · Cited by 55
Cucinotta, D., Luca, F. D., Gigante, A., Arrigo, T., Benedetto, A. D., Tedeschi, A., Lombardo, F., Romano, G., & Sferlazzas, C. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300253 · Cited by 47
Oxidative stress and cystic fibrosis-related diabetes: A pilot study in children
Ntimbane, T., Krishnamoorthy, P., Huot, C., Legault, L., Jacob, S. V., Brunet, S., Levy, E. H., Guéraud, F., Lands, L. C., & Comte, B. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.01.004 · Cited by 45
New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis: Fig. 1—
Müller-Brandes, C., Holl, R. W., Nastoll, M., & Ballmann, M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00068104 · Cited by 41
Stalvey, M. S., Muller, C., Schatz, D., Wasserfall, C. H., Campbell‐Thompson, M., Theriaque, D. W., Flotte, T. R., & Atkinson, M. A. (2006) · Diabetes · doi:10.2337/db05-1647 · Cited by 40
Brusco, A., Michielotto, C., Gatta, V., Foresta, C., Matullo, G., Zeviani, M., Ferrari, G., Dragone, E., Calabrese, G., Rossato, M., et al. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349169 · Cited by 39
Calpain 10 and development of diabetes mellitus in cystic fibrosis
Derbel, S., Doumaguet, C., Hubert, D., Mosnier-Pudar, H., Grabar, S., Chelly, J., & Bienvenu, T. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2005.09.011 · Cited by 36
Arrigo, T., Cucinotta, D., Nibali, S. C., Cesare, E. D., Benedetto, A. D., Magazzù, G., & Luca, F. D. (1993) · Acta Paediatrica · doi:10.1111/j.1651-2227.1993.tb12653.x · Cited by 34
Effects of feeding on protein turnover in healthy children and in children with cystic fibrosis
Kien, C. L., Zipf, W. B., Ca, H., Denne, S. C., McCoy, K., & O’Dorisio, T. M. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.4.608 · Cited by 31
Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells?
Ali, B. R. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.058 · Cited by 29
Moran, A., Basu, R., Milla, C. E., & Jensen, M. D. (2004) · Metabolism · doi:10.1016/j.metabol.2004.06.015 · Cited by 27
Self-citationCucinotta, D., Luca, F. D., Arrigo, T., Benedetto, A. D., Sferlazzas, C., Gigante, A., Rigoli, L. C., & Magazzù, G. (1994) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1994.7.1.13 · Cited by 26
Holl, R. W., Wolf, A. M., Thon, A., Bernhard, M. E., Buck, C., Missel, M., Heinze, E., von der Hardt, H., & Teller, W. M. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199708000-00010 · Cited by 26
Elevated Hepatic Glucose Production in Children with Cystic Fibrosis
Kien, C. L., Horswill, C. A., Zipf, W. B., McCoy, K., & O’Dorisio, T. M. (1995) · Pediatric Research · doi:10.1203/00006450-199505000-00007 · Cited by 25
Role of autoimmunity in insulinopenia and carbohydrate derangements associated with cystic fibrosis
Geffner, M. E., Lippe, B. M., Maclaren, N. K., & Riley, W. J. (1988) · The Journal of Pediatrics · doi:10.1016/s0022-3476(88)80324-x · Cited by 24
Sex Disparities in Effects of Cystic Fibrosis‐Related Diabetes on Clinical Outcomes: A Matched Study
Miller, R. J. H., Tildesley, H. D., Wilcox, P., Zhang, H., & Kreisman, S. H. (2008) · Canadian Respiratory Journal · doi:10.1155/2008/697186 · Cited by 20
Cystic fibrosis related diabetes in an extremely young patient
Casas, L., Berry, D., Logan, K., et al. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.08.004 · Cited by 16
A teenage girl with cystic fibrosis-related diabetes, diabetic ketoacidosis, and cerebral edema
Swartz, L. M., & Laffel, L. M. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00359.x · Cited by 16
Diabetes in an infant with cystic fibrosis
Lombardi, F., Raia, V., Spagnuolo, M. I., et al. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00069.x · Cited by 16
Diabetic Ketoacidosis in Cystic Fibrosis
Atlas, A. B. (1992) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1992.02160240067022 · Cited by 15
Hyperglycaemia and insulinopenia in a neonate with cystic fibrosis
Siahanidou, T., Mandyla, H., Doudounakis, S. E., et al. (2005) · Acta Paediatrica · doi:10.1111/j.1651-2227.2005.tb01864.x · Cited by 12
Infancy-Onset Cystic Fibrosis–Related Diabetes
Gelfand, I. M., Eugster, E. A., & Haddad, N. G. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2593 · Cited by 11
Cited by
Pancreatogenic Diabetes: Special Considerations for Management
Cui, Y., & Andersen, D. K. (2011) · Pancreatology · doi:10.1159/000329188 · Cited by 256
Diabetes mellitus secondary to pancreatic diseases (type 3c)—are we neglecting an important disease?
Ewald, N., & Bretzel, R. G. (2013) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2012.12.017 · Cited by 235
New insights into cystic fibrosis-related diabetes in children
Ode, K. L., & Moran, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70015-9 · Cited by 76
Self-citationCFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells
Edlund, A., Pedersen, M. G., Lindqvist, A., Wierup, N., Flodström-Tullberg, M., & Eliasson, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00098-8 · Cited by 63
Gilmour, J. A., Sykes, J., Etchells, E., & Tullis, E. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2018.04.008 · Cited by 51
Metadata
- Authors
- Moran, A., Becker, D., Casella, S. J., Gottlieb, P. A., Kirkman, M. S., Marshall, B. C., Slovis, B., & the CFRD Consensus Conference Committee
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-12-01
- Volume
- 33
- Issue
- 12
- Pages
- 2677-2683
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2167789521
- Cited by
- 258
- References
- 70
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.